High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response

Academic Radiology

Volumn 20, Issue 5, 2013, Pages 581-589

  Wilmes, Lisa J ^a   McLaughlin, Rebekah L ^a   Newitt, David C ^a   Singer, Lisa ^a   Sinha, Sumedha P ^a   Proctor, Evelyn ^a   Wisner, Dorota J ^a   Saritas, Emine U ^b   Kornak, John ^a   Shankaranarayanan, Ajit ^c   Banerjee, Suchandrima ^c   Jones, Ella F ^a   Joe, Bonnie N ^a   Hylton, Nola M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c GE HEALTHCARE   (United States)

Author keywords

ADC; Apparent diffusion coefficient; Breast cancer; Diffusion weighted magnetic resonance imaging; DWI; Treatment response

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CORRELATION COEFFICIENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOGRAM; HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION MONITORING; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; BRIDGED COMPOUNDS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TAXOIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875875816     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2013.01.009     Document Type: Article

References (27)

1. Bonadonna G., Valagussa P., Brambilla C., et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 1998, 16:93-100.
2. Partridge S.C., Gibbs J.E., Lu Y., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005, 1184:1774-1781.
3. Ah-See M.L., Makris A., Taylor N.J., et al. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res 2008, 14:6580-6589.
4. Pickles M.D., Gibbs P., Lowry M., et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006, 24:843-847.
5. Sinha S., Lucas-Quesada F.A., Sinha U., et al. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002, 15:693-704.
6. Sharma U., Danishad K.K., Seenu V., et al. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009, 22:104-113.
7. Park M.J., Cha E.S., Kang B.J., et al. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007, 8:390-396.
8. Partridge S.C., DeMartini W.B., Kurland B.F., et al. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 2009, 193:1716-1722.
9. Park S.H., Moon W.K., Cho N., et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 2010, 257:56-63.
10. Iacconi C., Giannelli M., Marini C., et al. The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol 2010, 20:303-308.
11. Fangberget A., Nilsen L.B., Hole K.H., et al. Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 2011, 21:1188-1199.
12. Manton D.J., Chaturvedi A., Hubbard A., et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006, 94:427-435.
13. Nilsen L., Fangberget A., Geier O., et al. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010, 49:354-360.
14. Tozaki M., Oyama Y., Fukuma E. Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging. Jpn J Radiol 2010, 28:101-109.
15. Partridge S.C., Singer L., Sun R., et al. Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements. Magn Reson Imaging 2011, 29:1215-1221.
16. Jezzard P., Balaban R.S. Correction for geometric distortion in echo planar images from B0 field variations. Magn Reson Med 1995, 34:65-73.
17. Saritas E.U., Cunningham C.H., Lee J.H., et al. DWI of the spinal cord with reduced FOV single-shot EPI. Magn Reson Med 2008, 60:468-473.
18. Wilm B.J., Svensson J., Henning A., et al. Reduced field-of-view MRI using outer volume suppression for spinal cord diffusion imaging. Magn Reson Med 2007, 57:625-630.
19. Wheeler-Kingshott C.A., Hickman S.J., Parker G.J., et al. Investigating cervical spinal cord structure using axial diffusion tensor imaging. Neuroimage 2002, 16:93-102.
20. Singer L., Wilmes L.J., Saritas E.U., et al. High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. Acad Radiol 2012, 19:526-534.
21. Partridge S.C., Gibbs J.E., Lu Y., et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002, 179:1193-1199.
22. Prasad S.R., Jhaveri K.S., Saini S., et al. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 2002, 225:416-419.
23. Partridge S.C., Rahbar H., Murthy R., et al. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med 2011, 65:1759-1767.
24. Jensen L.R., Garzon B., Heldahl M.G., et al. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients. J Magn Reson Imaging 2011, 34:1099-1109.
25. Yankeelov T.E., Lepage M., Chakravarthy A., et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007, 25:1-13.
26. Iacconi C., Giannelli M. Can diffusion-weighted MR imaging be used as a biomarker for predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer?. Radiology 2011, 259:303-304.
27. Belli P., Costantini M., Ierardi C., et al. Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment. Breast J 2011, 17:610-619.